Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)

OBJECTIVE: Antipsychotic‐induced weight gain (AiWG) is a debilitating adverse effect of most antipsychotics. First‐episode psychosis patients are particularly vulnerable to the detrimental consequences of AiWG. Amisulpride has good efficacy and tolerability. We here aimed to identify the phenotypic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, R., Cianci, D., ter Hark, S. E., Winter‐van Rossum, I., Ebdrup, B. H., Broberg, B. V., Garcia‐Portilla, M. P., Bobes, J., Vinkers, C. H., Kahn, R. S., Guloksuz, S., Huitema, A. D. R., Luykx, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771865/
https://www.ncbi.nlm.nih.gov/pubmed/31323113
http://dx.doi.org/10.1111/acps.13074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771865/
https://www.ncbi.nlm.nih.gov/pubmed/31323113
http://dx.doi.org/10.1111/acps.13074

Ejemplares similares